Research ArticleArticle
Malignancies in Giant Cell Arteritis: A Population-based Cohort Study
Pavlos Stamatis, Carl Turesson, Minna Willim, Jan-Åke Nilsson, Martin Englund and Aladdin J. Mohammad
The Journal of Rheumatology June 2019, jrheum.190236; DOI: https://doi.org/10.3899/jrheum.190236
Pavlos Stamatis
From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopaedics and Clinical Epidemiology Unit, Lund; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and the Swedish Medical Association (Läkarsällskapet SLS-783621). P. Stamatis, MD, Consultant in Rheumatology, Department of Clinical Sciences Lund, Rheumatology, Lund University; C. Turesson, MD, PhD, Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences Malmö, Rheumatology, Lund University; M. Willim, IT Coordinator, Department of Clinical Sciences Lund, Rheumatology, Lund University; J.Å. Nilsson, PhD, Statistician, Department of Clinical Sciences Lund, Rheumatology, Lund University; M. Englund, MD, PhD, Professor of Epidemiology, Department of Clinical Sciences, Lund, Clinical Epidemiology Unit; A.J. Mohammad, MD, PhD, Associate Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. P. Stamatis, Department of Rheumatology, Skåne University Hospital, Lund, SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se. Accepted for publication May 8, 2019.
Carl Turesson
From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopaedics and Clinical Epidemiology Unit, Lund; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and the Swedish Medical Association (Läkarsällskapet SLS-783621). P. Stamatis, MD, Consultant in Rheumatology, Department of Clinical Sciences Lund, Rheumatology, Lund University; C. Turesson, MD, PhD, Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences Malmö, Rheumatology, Lund University; M. Willim, IT Coordinator, Department of Clinical Sciences Lund, Rheumatology, Lund University; J.Å. Nilsson, PhD, Statistician, Department of Clinical Sciences Lund, Rheumatology, Lund University; M. Englund, MD, PhD, Professor of Epidemiology, Department of Clinical Sciences, Lund, Clinical Epidemiology Unit; A.J. Mohammad, MD, PhD, Associate Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. P. Stamatis, Department of Rheumatology, Skåne University Hospital, Lund, SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se. Accepted for publication May 8, 2019.
Minna Willim
From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopaedics and Clinical Epidemiology Unit, Lund; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and the Swedish Medical Association (Läkarsällskapet SLS-783621). P. Stamatis, MD, Consultant in Rheumatology, Department of Clinical Sciences Lund, Rheumatology, Lund University; C. Turesson, MD, PhD, Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences Malmö, Rheumatology, Lund University; M. Willim, IT Coordinator, Department of Clinical Sciences Lund, Rheumatology, Lund University; J.Å. Nilsson, PhD, Statistician, Department of Clinical Sciences Lund, Rheumatology, Lund University; M. Englund, MD, PhD, Professor of Epidemiology, Department of Clinical Sciences, Lund, Clinical Epidemiology Unit; A.J. Mohammad, MD, PhD, Associate Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. P. Stamatis, Department of Rheumatology, Skåne University Hospital, Lund, SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se. Accepted for publication May 8, 2019.
Jan-Åke Nilsson
From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopaedics and Clinical Epidemiology Unit, Lund; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and the Swedish Medical Association (Läkarsällskapet SLS-783621). P. Stamatis, MD, Consultant in Rheumatology, Department of Clinical Sciences Lund, Rheumatology, Lund University; C. Turesson, MD, PhD, Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences Malmö, Rheumatology, Lund University; M. Willim, IT Coordinator, Department of Clinical Sciences Lund, Rheumatology, Lund University; J.Å. Nilsson, PhD, Statistician, Department of Clinical Sciences Lund, Rheumatology, Lund University; M. Englund, MD, PhD, Professor of Epidemiology, Department of Clinical Sciences, Lund, Clinical Epidemiology Unit; A.J. Mohammad, MD, PhD, Associate Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. P. Stamatis, Department of Rheumatology, Skåne University Hospital, Lund, SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se. Accepted for publication May 8, 2019.
Martin Englund
From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopaedics and Clinical Epidemiology Unit, Lund; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and the Swedish Medical Association (Läkarsällskapet SLS-783621). P. Stamatis, MD, Consultant in Rheumatology, Department of Clinical Sciences Lund, Rheumatology, Lund University; C. Turesson, MD, PhD, Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences Malmö, Rheumatology, Lund University; M. Willim, IT Coordinator, Department of Clinical Sciences Lund, Rheumatology, Lund University; J.Å. Nilsson, PhD, Statistician, Department of Clinical Sciences Lund, Rheumatology, Lund University; M. Englund, MD, PhD, Professor of Epidemiology, Department of Clinical Sciences, Lund, Clinical Epidemiology Unit; A.J. Mohammad, MD, PhD, Associate Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. P. Stamatis, Department of Rheumatology, Skåne University Hospital, Lund, SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se. Accepted for publication May 8, 2019.
Aladdin J. Mohammad
From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopaedics and Clinical Epidemiology Unit, Lund; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and the Swedish Medical Association (Läkarsällskapet SLS-783621). P. Stamatis, MD, Consultant in Rheumatology, Department of Clinical Sciences Lund, Rheumatology, Lund University; C. Turesson, MD, PhD, Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences Malmö, Rheumatology, Lund University; M. Willim, IT Coordinator, Department of Clinical Sciences Lund, Rheumatology, Lund University; J.Å. Nilsson, PhD, Statistician, Department of Clinical Sciences Lund, Rheumatology, Lund University; M. Englund, MD, PhD, Professor of Epidemiology, Department of Clinical Sciences, Lund, Clinical Epidemiology Unit; A.J. Mohammad, MD, PhD, Associate Professor of Rheumatology, Senior Consultant Rheumatologist, Department of Clinical Sciences, Rheumatology, Clinical Epidemiology Unit, Lund University, and Department of Medicine, University of Cambridge. Address correspondence to Dr. P. Stamatis, Department of Rheumatology, Skåne University Hospital, Lund, SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se. Accepted for publication May 8, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Malignancies in Giant Cell Arteritis: A Population-based Cohort Study
Pavlos Stamatis, Carl Turesson, Minna Willim, Jan-Åke Nilsson, Martin Englund, Aladdin J. Mohammad
The Journal of Rheumatology Jun 2019, jrheum.190236; DOI: 10.3899/jrheum.190236